Distinct proteinase 3-induced cytokine patterns in Wegener's granulomatosis, Churg-Strauss syndrome, and healthy controls

Clinical and Experimental Rheumatology

Volumn 29, Issue 1 SUPPL. 64, 2011, Pages

  Fagin, U ^a   Csernok, E ^a   Muller A ^a   Pitann, S ^a   Fazio, J ^b   Krause, K ^a   Bremer, P ^a   Wipfler Freissmuth E ^a,c   Moosig, F ^a   Gross, W L ^a   Lamprecht, Peter ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Churg Strauss syndrome; Proteinase 3; T cells; Th17; Th22; Wegener's granulomatosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; MYELOBLASTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MALE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL; WEGENER GRANULOMATOSIS; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIGENS; CASE-CONTROL STUDIES; CELL LINE; CHURG-STRAUSS SYNDROME; CYTOKINES; FEMALE; FLOW CYTOMETRY; GERMANY; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYELOBLASTIN; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH17 CELLS; TH2 CELLS; UP-REGULATION; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 79960427669     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BORG FA, DASGUPTA B: Treatment and outcomes of large vessel arteritis. Best Pract Res Clin Rheumatol 2009; 23: 325-37.
2. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
3. SABLÉ-FOURTASSOU R, COHEN P, MAHR A et al.: Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143: 632-8.
4. CHEN M, KALLENBERG CG: New advances in the pathogenesis of ANCA-associated vasculitides. Clin Exp Rheumatol 2009; 27 (Suppl. 52): S108-14.
5. LÚDVÍKSSON BR, SNELLER MC, CHUA KS et al.: Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998; 160: 3602-9.
6. KIENE M, CSERNOK E, MÜLLER A, METZLER C, TRABANDT A, GROSS WL: Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 2001; 44: 469-73.
7. POPA ER, FRANSSEN CF, LIMBURG PC, HUITEMA MG, KALLENBERG CG, TERVAERT JW: In vitro cytokine production and proliferation of T cells from patients with antiproteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum 2002; 46: 1894-1904.
8. ABDULAHAD WH, STEGEMAN CA, LIM-BURG PC, KALLENBERG CG: Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008; 58: 2196-205.
9. NOGUEIRA E, HAMOUR S, SAWANT D et al.: Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2010; 25: 2209-11.
10. HELLMICH B, FLOSSMANN O, GROSS WL et al.: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007; 66: 605-17.
11. KOMOCSI A, LAMPRECHT P, CSERNOK E et al.: Peripheral blood and granuloma CD4+CD28- T-cells are a major source of IFN-γ and TNF-α in Wegerner's granulomatosis. Am J Pathol 2002; 160: 1717-24.
12. SAITO H, TSURIKISAWA N, TSUBURAI T, OSHIKATA C, AKIYAMA K: Cytokine production profile of CD4+ T cells from patients with active Churg Strauss syndrome tends towards Th17. Int Arch Allergy Immunol 2009; 149(Supll. 1): S61-5.
13. LIANG SC, TAN XY, LUXENBERG DP et al.: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006; 203: 2271-9.
14. DI GIACINTO C, MARINARO M, SANCHEZ M, STROBER W, BOIRIVANT M: Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 2005; 174: 3237-46.
15. SCHÖNERMARCK U, LAMPRECHT P, CSERNOK E, GROSS WL: Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 2001; 40: 178-84.
16. MISRA N, MURTAZA A, WALKER B et al.: Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarised T-helper subsets: T-helper phenotypeis stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 1995; 86: 97-103.
17. ARIF S, TREE TI, ASTILL TP et al.: Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113: 451-63.
18. STEGEMAN CA, TERVAERT JW, SLUITER WJ, MANSON WL, DE JONG PE, KALLENBERG CG: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994; 120: 12-7.
19. YE P, RODRIGUEZ FH. KANALY S et al.: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-27.
20. ANNUNZIATO F, COSMI L, SANTARLASCI V et al.: Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-61.
21. COSMI L, MAGGI L, SANTARLASCI V et al.: Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125: 222-30.
22. DUHEN T, GEIGER R, JARROSSAY D, LANZAVECCHIA A, SALLUSTO F: Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10: 857-63.
23. KROENKE MA, CARLSON TJ, ANDJELKOVIC AV, SEGAL BM: IL-12 and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008; 205: 1535-41.
24. HSU HC, YANG P, WANG J et al.: Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 166-75.
25. BARAN J, KOWALCZYK D, OZOG M, ZEMBALA M: Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin Diagn Lab Immunol 2001; 8: 303-13.
26. ZINKERNAGEL RM, HENGARTNER H: Regulation of the immune response by antigen. Science 2001; 293: 251-3.
27. LAMPRECHT P, VARGAS CUERO AL, MULLER A et al.: Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosis. Cell Immunol 2003; 224: 1-7.